Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00441935 · ClinicalTrials.gov registry record
InterStim Prospective Database
A clinical trial, sponsored by Kenneth Peters, MD.
- Terminated
- Registry status
- 736
- Enrollment target
NCT00441935: Clinical Trial study, sponsored by Kenneth Peters, MD.
NCT00441935 is a clinical trial that was terminated before completion, run by Kenneth Peters, MD. The registered enrollment target is 736 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00441935 was terminated before completion, sponsored by Kenneth Peters, MD.
- TERMINATED
- Registry status
- 736 participants
- Enrollment target
Study Summary
The study is to collect information from patient charts and patient questionnaires to evaluate the effects of nerve stimulation therapy on urinary dysfunction.
Interventions
- DEVICE Interstim Neuromodulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 736 participants |
| Start Date | 2004-04 |
| Est. Completion | 2016-12-16 |
Why NCT00441935 stopped before completion
NCT00441935 is an observational study that tracks outcomes without assigning an intervention. The registered 736 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Interstim Neuromodulation is the first listed.
NCT00441935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00441935 about?
NCT00441935 is a clinical study titled "InterStim Prospective Database". The study is to collect information from patient charts and patient questionnaires to evaluate the effects of nerve stimulation therapy on urinary dysfunction.
What is the current status of trial NCT00441935?
This trial is currently terminated. The enrollment target is 736 participants. The study started on 2004-04. Estimated completion is 2016-12-16.
What interventions are being tested in trial NCT00441935?
The interventions under investigation include: Interstim Neuromodulation (DEVICE).
Who is sponsoring clinical trial NCT00441935?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05796141 · 736 participants · NA
Becoming United in Lifestyle Decisions
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- NCT06825689 · 735 participants · NA
Unidos Contra el VPH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia